Last reviewed · How we verify
NCT06116162
Comparison of SVF-gel Filling and CO2 Fractional Laser on Atrophic Acne Scar Treatment
NA trial testing SVF-gel Filling and CO2 fractional laser in Autologous Fat Graft Harvesting, SVF-gel Preparation and Filling in 18 participants. Completed in 20 January 2023.
20 July 2022
Quick facts
| Lead sponsor | Xijing Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | single group |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 18 |
| Start date | 20 January 2021 |
| Primary completion | 20 July 2022 |
| Estimated completion | 20 January 2023 |
| Sites | 2 locations across China |
Drugs / interventions tested
- SVF-gel Filling and CO2 fractional laser
Conditions studied
- Autologous Fat Graft Harvesting, SVF-gel Preparation and Filling — all drugs for Autologous Fat Graft Harvesting, SVF-gel Preparation and Filling →
- CO2 Fractional Laser Treatment by Using Acupulse Device — all drugs for CO2 Fractional Laser Treatment by Using Acupulse Device →
Sponsor
Xijing Hospital
Who can join
Adults 16 to 35, any sex, with Autologous Fat Graft Harvesting, SVF-gel Preparation and Filling or CO2 Fractional Laser Treatment by Using Acupulse Device. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Background Adipose extracellular matrix/stromal vascular fraction gel(SVF-gel), which contains adipose-derived stem cells, endothelial cells, smooth muscle cells, pericytes, and other cell components. Objective To determine the efficacy and safety of SVF-gel for treating acne scars and to compare the results with CO2 fractional laser. Methods Seventeen patients with moderate to severe acne scars were treated with SVF-gel filling and CO2 fractional laser through a 24-week, randomized split-face study. One randomly assigned half side of each patient's received one SVF-gel filling treatment and the other side by two CO2 fractional laser treatment once one months. Clinical improvement was assessed by two blinded investigators with Echelle d'Evaluation Clinique des Cicatrices d'acne (ECCA) scale, VISIA and Antaro-3D detection.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Comparison of the Effects of Adipose Extracellular Matrix/Stromal Vascular Fraction Gel Injection and CO<sub>2</sub> Fractional Laser on Atrophic Acne Scar in Asians Through a 24-Week Prospective, Randomized, Split-Face Study.
Zhao T, Li M, Wang J, Liu J, et al · · 2025 · cited 1× · PMID 40112029 · DOI 10.1111/jocd.70131
Verify or expand the search:
- PubMed search for NCT06116162
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Xijing Hospital trials
Trials by the same sponsor.
- NCT07532096 — Extended Sentinel Lymph Node Biopsy With Methylene Blue Single Tracer Post-Neoadjuvant Therapy for Node-Positive Breast · NA · not yet recruiting
- NCT07519018 — TIS for Drug Resistant TLE · NA · not yet recruiting
- NCT07518992 — Correlation Between Preoperative Sleep and Postoperative Brain and Renal Dysfunction · not yet recruiting
- NCT07466303 — Serplulimab Combined With Trastuzumab Rezetecan as Neoadjuvant Therapy for Triple-Negative Breast Cancer · Phase 2 · not yet recruiting
- NCT07474142 — A Multicenter, Prospective Study on the Prognostic Value of PSMA PET in Patients With Newly Diagnosed, Treatment-naïve P · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06116162 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Xijing Hospital
- Last refreshed: 3 November 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06116162.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing